Skip to content

Clinical trials

Lymphoma, Follicular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Follicular Country / region: China Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20103
20111
20122
20135
20142
20154
20165
201710
20189
20196
202010
202110
202213
202310
202417
202515
202622

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting48
Unknown status37
Completed22
Not yet recruiting17
Active, not recruiting12
Terminated6
Enrolling by invitation3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital6
Ruijin Hospital6
PersonGen BioTherapeutics (Suzhou) Co., Ltd.5
BeiGene4
China-Japan Friendship Hospital4
Institute of Hematology & Blood Diseases Hospital, China4
Sun Yat-sen University4
The First Affiliated Hospital of Xiamen University4
AstraZeneca3
BeOne Medicines3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Follicular146
Lymphoma, Large B-Cell, Diffuse36
Lymphoma, Mantle-Cell32
Lymphoma, B-Cell, Marginal Zone22
Leukemia, Lymphocytic, Chronic, B-Cell21
Lymphoma, Non-Hodgkin14
Lymphoma, B-Cell13
Lymphoma11
Recurrence10
Hematologic Neoplasms6

Trials

Showing 26 to 50 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.